Few studies have investigated whether activating mutation in RAS genes, previously associated with pathogenesis of follicular tumors [20-22], may cooperate with PAX8/PPARγ rearrangement in the pathogenesis of FTC. The gene discussed is PAX8; the disease is thyroid cancer, nonmedullary, 2.